FDG PET scan, DOTATATE PET CT, and PSMA PET CT are advanced medical imaging techniques used in the detection and diagnosis of various cancers. FDG PET utilizes a radiolabeled sugar to identify metabolically active areas within the body. DOTATATE PET uses a radionuclide labeled with Dotatate, a somatostatin analog, to target and image somatostatin receptor positive tumors such as neuroendocrine cancers. PSMA PET uses gallium or zirconium-labeled Prostate-specific membrane antigen (PSMA), binding specifically to overexpressed PSMA receptors in prostate cancer.
FDG PET scan, DOTATATE PET CT, and PSMA PET CT are advanced medical imaging techniques used in the detection and diagnosis of various cancers. FDG PET utilizes a radiolabeled sugar to identify metabolically active areas within the body. DOTATATE PET uses a radionuclide labeled with Dotatate, a somatostatin analog, to target and image somatostatin receptor positive tumors such as neuroendocrine cancers. PSMA PET uses gallium or zirconium-labeled Prostate-specific membrane antigen (PSMA), binding specifically to overexpressed PSMA receptors in prostate cancer.